NEW YORK, November 24, 2022 /PRNewswire/ —
WHY: Rosen Law Firm, a global investor rights law firm, reminds buyers of Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) securities between March 10, 2021 and October 4, 2022, both dates inclusive (the “Class Period”), of the important January 9, 2023 lead applicant deadline.
SO WHAT: If you purchased Eiger securities during the Class Period, you may be entitled to compensation without payment of fees or out-of-pocket expenses through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Eiger class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=9654 or call Phillip Kim, Esq. toll free at 866-767-3653 or by email [email protected] Where [email protected] for more information on the class action. A class action lawsuit has already been filed. If you wish to act as lead plaintiff, you must move the Court not later than January 9, 2023. A lead plaintiff is a representative party acting on behalf of other class members to direct litigation.
WHY THE ROSEN LAW: We encourage investors to select qualified attorneys with proven track records in leadership roles. Often, companies issuing reviews do not have comparable experience, resources, or significant peer recognition. Many of these firms do not actually handle securities class action lawsuits, but are merely middlemen who refer clients or partner with law firms that actually litigate the cases. Be wise in choosing lawyers. Rosen Law Firm represents investors worldwide, focusing its practice on securities class action and shareholder derivative litigation. Rosen Law Firm has reached the largest securities class action settlement against a Chinese company. Rosen Law Firm was ranked #1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017. The firm has ranked in the top 4 every year since 2013 and has recovered hundreds of million dollars for investors. In 2019 alone, the company obtained more than $438 million for investors. In 2020, founding partner Laurence Rosen has been named by law360 as a Titan of the Plaintiffs Bar. Many of the firm’s lawyers have been recognized by Lawdragon and Super Lawyers.
CASE DETAILS: According to the lawsuit, throughout the Class Period, the Defendants made false and/or misleading statements and/or failed to disclose that: (1) the Defendants exaggerated Eiger’s clinical and regulatory expertise in drug development; (2) Defendants failed to properly assess and/or ignored issues with the design of the TOGETHER study and its ability to support emergency use authorization of peginterferon lambda (“EUA”); (3) there were problems with driving the TOGETHER study and/or TOGETHER the study was not properly designed for peginterferon lambda EUA in the current context of the pandemic; (4) as a result, the US Food and Drug Administration was unlikely to approve the submission of an EUA for peginterferon lambda; (5) as a result of all of the above, the regulatory and commercial prospects of peginterferon lambda for the treatment of COVID-19 have been overstated; and (6) therefore, Eiger’s public statements were materially false and misleading at all relevant times. When the real details entered the market, the lawsuit claims investors suffered damages.
To join the Eiger class action lawsuit, go to https://rosenlegal.com/submit-form/?case_id=9654 or call Phillip Kim, Esq. toll free at 866-767-3653 or by email [email protected] Where [email protected] for more information on the class action.
No class has been certified. Until a class is certified, you are not represented by an attorney unless you retain one. You can choose the lawyer of your choice. You can also remain an absent group member and do nothing at this point. An investor’s ability to participate in any potential future recovery does not depend on their status as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Lawyer advertisement. Previous results do not guarantee a similar result.
Contact information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, Pennsylvania
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
[email protected]
[email protected]
[email protected]
www.rosenlegal.com
SOURCE Rosen Law Firm, Pennsylvania